Novartis Ag (NVS) Current Leases (2019 - 2026)

Novartis Ag has disclosed Current Leases across 8 years of filings, most recently posting $274.0 million for Q2 2026.

• In Q2 2026, Current Leases rose 5.79% year-over-year to $274.0 million; the TTM figure through Jun 2026 stood at $274.0 million (up 5.79% YoY), while the FY2025 annual figure was $263.0 million, up 11.91% from the prior year.
• Current Leases came in at $274.0 million for Q2 2026 at Novartis Ag, up from $271.0 million in the prior quarter.
• In the past five years, Current Leases ranged from a high of $274.0 million in Q2 2026 to a low of $210.0 million in Q3 2023.
• Average Current Leases over 5 years is $248.8 million, with a median of $249.5 million recorded in 2022.
• Year-over-year, Current Leases decreased 15.32% in 2023 and increased 17.62% in 2024.
• Over 5 years, Current Leases stood at $251.0 million in 2022, then dropped by 8.37% to $230.0 million in 2023, then increased by 2.17% to $235.0 million in 2024, then climbed by 11.91% to $263.0 million in 2025, then climbed by 4.18% to $274.0 million in 2026.
• Per Business Quant data, the three most recent Current Leases figures were $274.0 million in Q2 2026, $271.0 million in Q1 2026, and $263.0 million in Q4 2025.